Mexico's antitrust watchdog say more generic drug competition needed
Mexico's antitrust watchdog says the country needs to remove regulatory barriers to generic drug competition.
To read more
Subscribe to Latin Lawyer
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Latin Lawyer experts.